Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-TRC-10000809Phase 4Completed
Phase 4, randomised, open-label trial of tirofiban in acute coronary syndrome (ACS) (6 arms), sponsored by Henan Provincial People's Hospital. Primary endpoint: Major adverse cardiac events. Started May 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-TRC-10000809.